MCID: OVR059
MIFTS: 50

Ovary Adenocarcinoma

Categories: Cancer diseases, Endocrine diseases, Rare diseases, Reproductive diseases

Aliases & Classifications for Ovary Adenocarcinoma

MalaCards integrated aliases for Ovary Adenocarcinoma:

Name: Ovary Adenocarcinoma 12 15
Ovarian Adenocarcinoma 12 59 6 73
Adenocarcinoma of the Ovary 12
Adenocarcinoma of Ovary 59
Ovarian Adenoacanthoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3713
NCIt 50 C7700
Orphanet 59 ORPHA213504
ICD10 via Orphanet 34 C56
UMLS via Orphanet 74 C0948216
UMLS 73 C0948216

Summaries for Ovary Adenocarcinoma

Disease Ontology : 12 An ovarian carcinoma that derives from epithelial cells of glandular origin.

MalaCards based summary : Ovary Adenocarcinoma, also known as ovarian adenocarcinoma, is related to ovarian cystadenocarcinoma and clear cell adenocarcinoma. An important gene associated with Ovary Adenocarcinoma is ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2), and among its related pathways/superpathways are Endometrial cancer and Pathways in cancer. Affiliated tissues include ovary, liver and lung, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Related Diseases for Ovary Adenocarcinoma

Diseases related to Ovary Adenocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 161)
# Related Disease Score Top Affiliating Genes
1 ovarian cystadenocarcinoma 31.8 ARL11 HRAS KRAS ZNF217
2 clear cell adenocarcinoma 31.1 ARID1A HNF1B KRT7
3 papillary adenocarcinoma 30.6 CEACAM5 ERBB2 KRT7 TP53
4 adenocarcinoma 30.5 ERBB2 HRAS KRAS TP53
5 ovarian cancer 29.7 BAX ERBB2 HNF1B KRAS KRT7 TP53
6 pancreatic cancer 29.5 BAX CEACAM5 ERBB2 HRAS KRAS TP53
7 ovarian cancer 1 29.1 ACSBG1 ARID1A CEACAM5 ERBB2 ESS2 HNF1B
8 clear cell adenocarcinoma of the ovary 12.4
9 mucinous adenocarcinoma of ovary 12.3
10 ovarian clear cell adenocarcinoma 11.1
11 ovarian mucinous adenocarcinoma 11.1
12 rete ovarii adenocarcinoma 11.1
13 ovary serous adenocarcinoma 11.1
14 mucinous adenocarcinoma 10.4
15 gastric papillary adenocarcinoma 10.3 ERBB2 TP53
16 rare adenocarcinoma of the breast 10.3 KRAS TP53
17 cutaneous mucoepidermoid carcinoma 10.3 CEACAM5 KRT7
18 reproductive system disease 10.3 ERBB2 ESS2 TP53
19 anal gland adenocarcinoma 10.3 CEACAM5 KRT7
20 uterine body mixed cancer 10.3 ARID1A ERBB2 TP53
21 vulvar intraepithelial neoplasia 10.3 KRT7 TP53
22 granulosa cell tumor of the ovary 10.3 ERBB2 KRT7 TP53
23 hidradenocarcinoma 10.3 ERBB2 KRT7 TP53
24 tonsil cancer 10.2 ERBB2 KRT7 TP53
25 intracystic papillary adenoma 10.2 CEACAM5 ERBB2
26 gallbladder squamous cell carcinoma 10.2 CEACAM5 ERBB2
27 cervical adenocarcinoma 10.2 ERBB2 KRT7 TP53
28 appendix disease 10.2 HRAS KRAS KRT7
29 sweat gland cancer 10.2 ERBB2 KRT7 TP53
30 pseudomyxoma peritonei 10.2 KRAS KRT7 TP53
31 ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 10.2 ARID1A KRAS TP53
32 epithelial-myoepithelial carcinoma 10.2 HRAS KRT7 TP53
33 anal canal adenocarcinoma 10.2 HRAS KRAS KRT7
34 mucinous adenofibroma 10.2 CEACAM5 KRT7
35 acneiform dermatitis 10.2 ERBB2 HRAS KRAS
36 barrett's adenocarcinoma 10.2 ERBB2 KRAS TP53
37 intracranial chondrosarcoma 10.2 CEACAM5 TP53
38 duodenum cancer 10.2 HRAS KRAS KRT7
39 anus adenocarcinoma 10.2 CEACAM5 KRT7
40 mucinous lung adenocarcinoma 10.2 ERBB2 HRAS KRAS
41 vulval paget's disease 10.2 CEACAM5 ERBB2 KRT7
42 adenosquamous carcinoma 10.2 KRAS KRT7 TP53
43 cecum adenocarcinoma 10.2 HRAS KRAS KRT7
44 krukenberg carcinoma 10.2 HNF1B KRT7
45 adenosquamous lung carcinoma 10.2 ERBB2 HRAS KRAS
46 vulva adenocarcinoma 10.2 CEACAM5 ERBB2 KRT7
47 periampullary adenoma 10.2 HRAS KRAS
48 malignant spiradenoma 10.2 CEACAM5 KRT7 TP53
49 small intestine cancer 10.2 HRAS KRAS KRT7
50 exanthem 10.2 ERBB2 HRAS KRAS

Graphical network of the top 20 diseases related to Ovary Adenocarcinoma:



Diseases related to Ovary Adenocarcinoma

Symptoms & Phenotypes for Ovary Adenocarcinoma

GenomeRNAi Phenotypes related to Ovary Adenocarcinoma according to GeneCards Suite gene sharing:

26 (show all 45)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-11 9.94 KRAS
2 Increased shRNA abundance (Z-score > 2) GR00366-A-115 9.94 INHBA
3 Increased shRNA abundance (Z-score > 2) GR00366-A-120 9.94 KRAS
4 Increased shRNA abundance (Z-score > 2) GR00366-A-122 9.94 ZNF217
5 Increased shRNA abundance (Z-score > 2) GR00366-A-123 9.94 POLE
6 Increased shRNA abundance (Z-score > 2) GR00366-A-127 9.94 ZNF217
7 Increased shRNA abundance (Z-score > 2) GR00366-A-131 9.94 ZNF217
8 Increased shRNA abundance (Z-score > 2) GR00366-A-147 9.94 ZNF217
9 Increased shRNA abundance (Z-score > 2) GR00366-A-151 9.94 ZNF217
10 Increased shRNA abundance (Z-score > 2) GR00366-A-159 9.94 ZNF217
11 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.94 ERBB2 ZNF217
12 Increased shRNA abundance (Z-score > 2) GR00366-A-163 9.94 ERBB2
13 Increased shRNA abundance (Z-score > 2) GR00366-A-168 9.94 ERBB2 KRAS POLE
14 Increased shRNA abundance (Z-score > 2) GR00366-A-177 9.94 KRAS
15 Increased shRNA abundance (Z-score > 2) GR00366-A-186 9.94 ZNF217
16 Increased shRNA abundance (Z-score > 2) GR00366-A-194 9.94 INHBA
17 Increased shRNA abundance (Z-score > 2) GR00366-A-196 9.94 KRAS
18 Increased shRNA abundance (Z-score > 2) GR00366-A-199 9.94 POLE
19 Increased shRNA abundance (Z-score > 2) GR00366-A-207 9.94 ERBB2 POLE
20 Increased shRNA abundance (Z-score > 2) GR00366-A-23 9.94 KRAS
21 Increased shRNA abundance (Z-score > 2) GR00366-A-25 9.94 ZNF217
22 Increased shRNA abundance (Z-score > 2) GR00366-A-32 9.94 ERBB2 POLE
23 Increased shRNA abundance (Z-score > 2) GR00366-A-49 9.94 KRAS
24 Increased shRNA abundance (Z-score > 2) GR00366-A-50 9.94 KRAS
25 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.94 ERBB2 INHBA KRAS POLE ZNF217
26 Increased shRNA abundance (Z-score > 2) GR00366-A-67 9.94 ZNF217
27 Increased shRNA abundance (Z-score > 2) GR00366-A-73 9.94 INHBA
28 Increased shRNA abundance (Z-score > 2) GR00366-A-83 9.94 ZNF217
29 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.94 ERBB2 POLE
30 Increased shRNA abundance (Z-score > 2) GR00366-A-93 9.94 KRAS
31 Increased shRNA abundance (Z-score > 2) GR00366-A-99 9.94 ZNF217
32 Decreased shRNA abundance (Z-score < -2) GR00366-A-1 9.91 POLE
33 Decreased shRNA abundance (Z-score < -2) GR00366-A-104 9.91 ZNF217
34 Decreased shRNA abundance (Z-score < -2) GR00366-A-148 9.91 ERBB2 ZNF217
35 Decreased shRNA abundance (Z-score < -2) GR00366-A-155 9.91 ZNF217
36 Decreased shRNA abundance (Z-score < -2) GR00366-A-173 9.91 ZNF217
37 Decreased shRNA abundance (Z-score < -2) GR00366-A-191 9.91 ZNF217
38 Decreased shRNA abundance (Z-score < -2) GR00366-A-216 9.91 ZNF217
39 Decreased shRNA abundance (Z-score < -2) GR00366-A-28 9.91 HRAS
40 Decreased shRNA abundance (Z-score < -2) GR00366-A-60 9.91 ERBB2
41 Decreased shRNA abundance (Z-score < -2) GR00366-A-68 9.91 HRAS
42 Decreased shRNA abundance (Z-score < -2) GR00366-A-77 9.91 ZNF217
43 Decreased shRNA abundance (Z-score < -2) GR00366-A-87 9.91 ERBB2 HRAS POLE ZNF217
44 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 9.91 POLE
45 Decreased shRNA abundance (Z-score < -2) GR00366-A-95 9.91 HRAS

MGI Mouse Phenotypes related to Ovary Adenocarcinoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.81 ACSBG1 ARID1A BAX ERBB2 HNF1B HRAS
2 neoplasm MP:0002006 9.5 ARID1A BAX ERBB2 HRAS KRAS POLE
3 renal/urinary system MP:0005367 9.17 BAX HNF1B HRAS INHBA KRAS KRT7

Drugs & Therapeutics for Ovary Adenocarcinoma

Search Clinical Trials , NIH Clinical Center for Ovary Adenocarcinoma

Genetic Tests for Ovary Adenocarcinoma

Anatomical Context for Ovary Adenocarcinoma

MalaCards organs/tissues related to Ovary Adenocarcinoma:

41
Ovary, Liver, Lung, Colon, Prostate, Pancreas, Appendix

Publications for Ovary Adenocarcinoma

Articles related to Ovary Adenocarcinoma:

(show top 50) (show all 247)
# Title Authors Year
1
Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. ( 29117515 )
2018
2
Paraneoplastic Cerebellar Degeneration Associated With Ovarian Adenocarcinoma: A Case Report and Review of Literature. ( 30532364 )
2018
3
Increased 131I Accumulation in the Gallbladder and High-grade Serous Ovarian Adenocarcinoma. ( 30371583 )
2018
4
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin. ( 30288129 )
2018
5
An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Müllerian Origin for Some Mesonephric Carcinomas. ( 28863071 )
2018
6
Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3. ( 28714011 )
2017
7
Sister Mary Joseph Nodule in an Ovary Adenocarcinoma. ( 28790552 )
2017
8
IMAGING DIAGNOSIS-COMPUTED TOMOGRAPHY FINDINGS IN A CASE OF METASTATIC OVARIAN ADENOCARCINOMA IN A DOG. ( 27734552 )
2017
9
Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma. ( 28050597 )
2017
10
Partial Cystectomy for Atypical Isolated Recurrence of Ovarian Adenocarcinoma - A Case Report and Literature Review. ( 28438874 )
2017
11
Early-Stage Mucinous Ovarian Adenocarcinoma with Extensive Clotting in a Previously Healthy Young Female Patient: An Uncommon Presentation of a Relatively Uncommon Disease. ( 28615616 )
2017
12
The expression profile and prognostic value of APE/Ref-1 and NPM1 in high-grade serous ovarian adenocarcinoma. ( 28766835 )
2017
13
p38MAPK family isoform p38α and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma. ( 28916425 )
2017
14
Genomic markers of ovarian adenocarcinoma and its relevancy to the effectiveness of chemotherapy. ( 28927094 )
2017
15
Gastric metastasis from ovarian adenocarcinoma presenting as a subepithelial tumor and diagnosed by endoscopic ultrasound-guided tissue acquisition. ( 29204254 )
2017
16
"On-The-Spot" Arresting of Chondroitin Sulphate Proteoglycans: Implications for Ovarian Adenocarcinoma Recognition and Intervention. ( 27438831 )
2016
17
MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib. ( 27465688 )
2016
18
Hypertrophic osteopathy secondary to metastatic ovarian adenocarcinoma in a mare. ( 27928168 )
2016
19
Reactive Oxygen Species and Serous Epithelial Ovarian Adenocarcinoma. ( 28503633 )
2016
20
Extremely low frequency electromagnetic field sensitizes cisplatin-resistant human ovarian adenocarcinoma cells via P53 activation. ( 26370097 )
2016
21
Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. ( 26721606 )
2016
22
Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression. ( 25971681 )
2015
23
Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells. ( 25561091 )
2015
24
Use of 3D Ultrasonography in Diagnosing Ovarian Adenocarcinoma in a Common Mynah ( Acridotheres tristis ). ( 26115215 )
2015
25
Identification of candidate biomarker mass (m/z) ranges in serous ovarian adenocarcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling. ( 26329525 )
2015
26
17β-Estradiol Stimulates Generation of Reactive Species Oxygen and Nitric Oxide in Ovarian Adenocarcinoma Cells (OVCAR 3). ( 26413252 )
2015
27
Synchronous pancreatic and gastric metastasis from an ovarian adenocarcinoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration. ( 26671541 )
2015
28
Immunophenotype and K-RAS mutation in mucinous ovarian adenocarcinoma with mural nodule of high-grade sarcoma: case report. ( 24487474 )
2014
29
Modulation of drug resistance in ovarian adenocarcinoma using chemotherapy entrapped in hyaluronan-grafted nanoparticle clusters. ( 24494862 )
2014
30
Interference of Ca²⁺ with the proliferation of SCCOHT-1 and ovarian adenocarcinoma cells. ( 24969518 )
2014
31
Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma. ( 23707658 )
2013
32
Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic? ( 23030299 )
2013
33
Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3. ( 23250740 )
2013
34
Pomolic acid induces apoptosis in SK-OV-3 human ovarian adenocarcinoma cells through the mitochondrial-mediated intrinsic and death receptor-induced extrinsic pathways. ( 23255955 )
2013
35
The role of estrogen in the survival of ovarian tumors--a study of the human ovarian adenocarcinoma cell lines OC-117-VGH and OVCAR3. ( 23351415 )
2013
36
Human erythropoietin increases the pro-angiogenic potential of A2780 ovarian adenocarcinoma cells under hypoxic conditions. ( 23807540 )
2013
37
A convenient synthesis of lubeluzole and its enantiomer: evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells. ( 23886686 )
2013
38
What is your diagnosis? Ovarian adenocarcinoma. ( 24344516 )
2013
39
Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis. ( 22826464 )
2012
40
Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma. ( 23056149 )
2012
41
Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to down-regulate Akt and MMP-2. ( 21740408 )
2012
42
Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma. ( 22330345 )
2012
43
Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cells. ( 22477337 )
2012
44
Bilateral ovarian adenocarcinoma in a mare causing haemoperitoneum and colic. ( 22480358 )
2012
45
Enlarged Virchow's node as an initial complaint of serous ovarian adenocarcinoma. ( 23185810 )
2012
46
CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma. ( 20571827 )
2011
47
Immunohistochemical evidence for the over-expression of Glutathione peroxidase 3 in clear cell type ovarian adenocarcinoma. ( 20730571 )
2011
48
Hemoperitoneum due to spontaneous rupture of ovarian adenocarcinoma. ( 21221696 )
2011
49
Solitary metastasis of a clear cell ovarian adenocarcinoma to the small bowel mucosa. ( 21272147 )
2011
50
Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780. ( 21676537 )
2011

Variations for Ovary Adenocarcinoma

ClinVar genetic disease variations for Ovary Adenocarcinoma:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 ERBB2 NM_001005862.2(ERBB2): c.2480A> G (p.Asn827Ser) single nucleotide variant Pathogenic/Likely pathogenic rs28933370 GRCh37 Chromosome 17, 37881378: 37881378
2 ERBB2 NM_001005862.2(ERBB2): c.2480A> G (p.Asn827Ser) single nucleotide variant Pathogenic/Likely pathogenic rs28933370 GRCh38 Chromosome 17, 39725125: 39725125

Copy number variations for Ovary Adenocarcinoma from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 118124 17 7571720 7590868 Mutation TP53 Ovarian adenocarcinomas

Expression for Ovary Adenocarcinoma

Search GEO for disease gene expression data for Ovary Adenocarcinoma.

Pathways for Ovary Adenocarcinoma

Pathways related to Ovary Adenocarcinoma according to GeneCards Suite gene sharing:

(show all 30)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.77 BAX ERBB2 HRAS KRAS TP53
2 12.73 BAX ERBB2 HRAS KRAS TP53
3
Show member pathways
12.66 BAX ERBB2 HRAS KRAS TP53
4
Show member pathways
12.59 BAX ERBB2 HRAS KRAS TP53
5
Show member pathways
12.51 ARID1A BAX ERBB2 HRAS KRAS TP53
6
Show member pathways
12.45 BAX ERBB2 HRAS KRAS TP53
7
Show member pathways
12.41 ERBB2 HRAS KRAS TP53
8
Show member pathways
12.39 BAX ERBB2 HRAS KRAS
9
Show member pathways
12.38 ERBB2 HRAS KRAS TP53
10
Show member pathways
12.25 BAX ERBB2 HRAS KRAS TP53
11 12.21 BAX HRAS KRAS POLE TP53
12 12.18 ERBB2 HRAS KRAS TP53
13 12.17 BAX HRAS KRAS TP53
14
Show member pathways
12.04 BAX ERBB2 HRAS KRAS TP53
15
Show member pathways
12.02 BAX HRAS KRAS TP53
16
Show member pathways
11.99 BAX HRAS KRAS TP53
17 11.87 BAX HRAS KRAS TP53
18 11.81 BAX HRAS KRAS
19 11.81 BAX ERBB2 HRAS KRAS TP53
20
Show member pathways
11.7 BAX HRAS KRAS
21 11.64 BAX ERBB2 TP53
22 11.57 HRAS KRAS TP53
23 11.49 ERBB2 HRAS KRAS TP53
24 11.48 ERBB2 HRAS KRAS
25 11.28 ARID1A ERBB2 HRAS TP53
26 11.21 HRAS KRAS TP53
27 11.13 ERBB2 HRAS KRAS
28 11.08 BAX ERBB2 HRAS KRAS TP53
29 11.07 ERBB2 HRAS KRAS TP53
30 10.73 HRAS KRAS

GO Terms for Ovary Adenocarcinoma

Biological processes related to Ovary Adenocarcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nervous system development GO:0007399 9.83 ARID1A BAX ERBB2 ESS2 INHBA
2 Ras protein signal transduction GO:0007265 9.58 HRAS KRAS TP53
3 positive regulation of MAP kinase activity GO:0043406 9.54 ERBB2 HRAS KRAS
4 aminoacyl-tRNA metabolism involved in translational fidelity GO:0106074 9.48 AARSD1 PTGES3L-AARSD1
5 tRNA aminoacylation GO:0043039 9.46 AARSD1 PTGES3L-AARSD1
6 regulation of translational fidelity GO:0006450 9.32 AARSD1 PTGES3L-AARSD1
7 response to isolation stress GO:0035900 9.26 HRAS KRAS
8 alanyl-tRNA aminoacylation GO:0006419 9.16 AARSD1 PTGES3L-AARSD1
9 intrinsic apoptotic signaling pathway GO:0097193 9.13 BAX HRAS TP53
10 positive regulation of gene expression GO:0010628 9.1 ERBB2 HNF1B HRAS INHBA KRAS TP53

Molecular functions related to Ovary Adenocarcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein heterodimerization activity GO:0046982 9.65 BAX ERBB2 HNF1B INHBA TP53
2 nucleotide binding GO:0000166 9.55 ACSBG1 ERBB2 HRAS KRAS POLE
3 alanine-tRNA ligase activity GO:0004813 8.96 AARSD1 PTGES3L-AARSD1
4 Ser-tRNA(Ala) hydrolase activity GO:0002196 8.62 AARSD1 PTGES3L-AARSD1

Sources for Ovary Adenocarcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....